← Open Payments lookup

RIMA HALL: Open Payments

NPI 1073195475 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$481 in 26 payments from 11 companies in 2025. Trend: 2023 $412 · 2024 $745 · 2025 $481

Food & beverage: $481
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$142
AstraZeneca Pharmaceuticals LP5$80
Axsome Therapeutics, Inc.2$46
ABBVIE INC.2$45
PFIZER INC.2$42
Novo Nordisk Inc1$33
Phathom Pharmaceuticals, Inc.2$31
GlaxoSmithKline, LLC.1$18
Abbott Laboratories1$16
Indivior Inc.1$15

Products named: CAPLYTA, Auvelity, VRAYLAR, Ozempic, VOQUEZNA, PAXLOVID, AIRSUPRA, TRELEGY ELLIPTA.

Industry payments across MI — which companies pay providers there.